FOXO TECHNOLOGIES INC. APIC, Share-based Payment Arrangement, Recognition and Exercise
FOXO TECHNOLOGIES INC. (FOXO) reported APIC, Share-based Payment Arrangement, Recognition and Exercise of -$269.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-06-06.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions · last filed 2024-06-06
- FOXO TECHNOLOGIES INC. apic, share-based payment arrangement, recognition and exercise for the quarter ending 2023-06-30 was $772.00K, a 202.75% increase year-over-year.
- FOXO TECHNOLOGIES INC. apic, share-based payment arrangement, recognition and exercise for the quarter ending 2022-06-30 was $255.00K.
- FOXO TECHNOLOGIES INC. apic, share-based payment arrangement, recognition and exercise for fiscal 2023 was -$269.00K, a 102.60% decline from fiscal 2022.
- FOXO TECHNOLOGIES INC. apic, share-based payment arrangement, recognition and exercise for fiscal 2022 was $10.36M.
| Period end | APIC, Share-based Payment Arrangement, Recognition and Exercise 3 month | APIC, Share-based Payment Arrangement, Recognition and Exercise 6 month | APIC, Share-based Payment Arrangement, Recognition and Exercise 12 month |
|---|---|---|---|
| 2023-12-31 | -$269.00K 10-K · filed 2024-06-06 | ||
| 2023-06-30 | $772.00K 10-Q · filed 2023-08-10 | $1.67M 10-Q · filed 2023-08-10 | |
| 2022-12-31 | $10.36M 10-K · filed 2024-06-06 | ||
| 2022-06-30 | $255.00K 10-Q · filed 2023-08-10 | $506.00K 10-Q · filed 2023-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |